about
Liposomes and nanotechnology in drug development: focus on ocular targetsNanogels of methylcellulose hydrophobized with N-tert-butylacrylamide for ocular drug delivery.Nanotechnology-based strategies for treatment of ocular disease.One-Year Feasibility Study of Replenish MicroPump for Intravitreal Drug Delivery: A Pilot Study.Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularizationChitosan grafted methoxy poly(ethylene glycol)-poly(ε-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac.Prophylactic effect of topical silica nanoparticles as a novel antineovascularization agent for inhibiting corneal neovascularization following chemical burn.A sustained intravitreal drug delivery system with remote real time monitoring capability.Nanotechnology in corneal neovascularization therapy--a reviewDiamond nanogel-embedded contact lenses mediate lysozyme-dependent therapeutic release.Poly(N-vinylpyrrolidone)-modified surfaces for biomedical applications.Critical assessment of implantable drug delivery devices in glaucoma management.Nanocarriers of nanotechnology in retinal diseases.Ocular delivery systems for topical application of anti-infective agents.Potential chitosan-coated alginate nanoparticles for ocular delivery of daptomycin.Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.Design and evaluation of proniosomes as a carrier for ocular delivery of lomefloxacin HCl.An Evaluation of the in vivo Safety of Nonporous Silica Nanoparticles: Ocular Topical Administration versus Oral Administration.The Effect of Silica Nanoparticles on Human Corneal Epithelial Cells.Conducting polymer nanoparticles decorated with collagen mimetic peptides for collagen targeting.Novel lutein loaded lipid nanoparticles on porcine corneal distribution.Supercritical fluid-mediated liposomes containing cyclosporin A for the treatment of dry eye syndrome in a rabbit model: comparative study with the conventional cyclosporin A emulsionFast Dissolving Dendrimer Nanofiber Mats as Alternative to Eye Drops for More Efficient Antiglaucoma Drug Delivery.Computational modeling of drug transport across the in vitro cornea.Hyaluronic Acid-Based Micelles as Ocular Platform to Modulate the Loading, Release, and Corneal Permeation of Corticosteroids.[Nanoparticles as drug delivery systems in ophthalmology].Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.Preparation and ocular pharmacokinetics of hyaluronan acid-modified mucoadhesive liposomes.Intranasal niosomes of nefopam with improved bioavailability: preparation, optimization, and in-vivo evaluationOcular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application
P2860
Q27687657-4368CA96-6D58-49FD-8F10-D05D6291521AQ31140602-8CDC2690-4A04-4F07-B215-78CBA154E0A1Q33681543-6DB7BA59-6B04-49C6-89DF-3AD123029069Q35167647-F6958238-FF43-4522-B72F-4EA947EB4DCAQ35224472-43B570B1-BEE9-4681-A04D-11BFEBB4A0AFQ35727894-FA28AF2E-814A-4B5D-B12A-1C2F06A57F15Q35884453-8A688B2F-4017-4ECA-B1E1-E669CF1AEB0DQ36029456-37388A8C-3E64-4A99-A565-CA39048BAF94Q36696450-98E7EA01-5098-4A50-B19D-FFE220E02FCAQ37731617-C4D10E71-9639-4289-906D-0C3A62F0E2D9Q38065133-63A4B898-F4D7-4DBD-AC96-99C343758DA3Q38143069-401087C7-6F5C-480D-9510-BB25000BBC80Q38282885-1B1AD9DD-7EE9-4B42-8AE3-1279EC1467BBQ38577846-AD4802E7-08DB-45B9-A9BC-35184EA06BDFQ38901841-E9A2E251-5ABE-42F4-A258-421A52A592B7Q39087808-E4AE05EC-8C7E-45BD-8ED2-35D38F5712F8Q40713954-C5D4A011-909B-4469-B7AF-76435BE9A2C0Q41423496-D4A7C5A9-9DFA-457E-AB78-FA0B6E1CEEC2Q41832878-D4BC44B1-5837-4010-9286-D8E28EB907C9Q42533421-A182A4F8-AA4D-428A-B0AB-699BA869EADFQ42738490-FD8CD9CE-6DBF-4375-AE1A-1A90940E9799Q42792794-9A8566E5-DFF7-4B3C-B9BC-FA8E77820401Q45073331-AE6E33FE-A769-4B4A-9A5A-1EB6399080D5Q47365514-6BCB76CD-92EB-461E-9421-08D9895D5D93Q49965212-B841CA0D-9B57-4B2C-AC1D-047B0C6575F2Q50129671-2C666AA0-021A-4561-9EC4-CEB9001DF74AQ52679059-69C377BF-7DAE-476D-B969-F4F0A7671469Q53655341-6E3BD73D-A304-4ADE-9A29-5651F3CEBCBCQ58605996-C9E94703-8304-4B87-8AC8-D4D572D76BFFQ58716234-A6CCB28B-8D12-48D6-9F9C-A8B1707A1F7D
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Nanomaterials for ocular drug delivery.
@en
type
label
Nanomaterials for ocular drug delivery.
@en
prefLabel
Nanomaterials for ocular drug delivery.
@en
P2860
P356
P1476
Nanomaterials for ocular drug delivery.
@en
P2093
Shengyan Liu
P2860
P304
P356
10.1002/MABI.201100419
P577
2012-04-17T00:00:00Z